Lucchese, Guglielmo
 Distribuzione geografica
Continente #
AS - Asia 1.773
NA - Nord America 1.129
EU - Europa 466
SA - Sud America 283
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 25
OC - Oceania 1
Totale 3.806
Nazione #
US - Stati Uniti d'America 1.058
SG - Singapore 1.010
IT - Italia 344
HK - Hong Kong 315
CN - Cina 281
BR - Brasile 228
VN - Vietnam 84
BD - Bangladesh 37
DE - Germania 30
AR - Argentina 25
GB - Regno Unito 25
CA - Canada 24
AT - Austria 19
MX - Messico 16
RU - Federazione Russa 12
IN - India 9
ZA - Sudafrica 9
EC - Ecuador 8
NL - Olanda 7
CR - Costa Rica 6
ID - Indonesia 6
IQ - Iraq 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
CO - Colombia 5
ES - Italia 5
JM - Giamaica 5
JP - Giappone 5
LT - Lituania 5
FR - Francia 4
MA - Marocco 4
NI - Nicaragua 4
PL - Polonia 4
UZ - Uzbekistan 4
CL - Cile 3
KE - Kenya 3
KW - Kuwait 3
PE - Perù 3
PR - Porto Rico 3
RO - Romania 3
TR - Turchia 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
LY - Libia 2
NP - Nepal 2
PK - Pakistan 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
EG - Egitto 1
GE - Georgia 1
HT - Haiti 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SE - Svezia 1
UA - Ucraina 1
Totale 3.677
Città #
Council Bluffs 347
Hong Kong 315
Singapore 251
Ashburn 159
San Jose 116
Beijing 114
Milan 112
Santa Clara 49
Rome 34
Ho Chi Minh City 24
Hanoi 22
Los Angeles 22
New York 18
Nuremberg 18
São Paulo 18
Miano 17
Turin 12
Vienna 10
Bari 9
Mexico City 9
Dallas 8
Rio de Janeiro 8
Johannesburg 7
London 7
Atlanta 6
Brooklyn 6
Carrboro 6
Abbeville 5
Belo Horizonte 5
Berlin 5
Charlotte 5
Naples 5
San José 5
Taranto 5
Tokyo 5
Brasília 4
Buenos Aires 4
Chicago 4
Duque de Caxias 4
Frankfurt am Main 4
Managua 4
Orem 4
Pescara 4
Phoenix 4
Quito 4
Quận Bốn 4
Tashkent 4
Toronto 4
Warsaw 4
Campinas 3
Casablanca 3
Centro Municipality 3
Chennai 3
Contagem 3
Da Nang 3
Guayaquil 3
Haiphong 3
Itaquaquecetuba 3
Lima 3
Manaus 3
Petrópolis 3
Piracicaba 3
Quảng Ninh 3
Reading 3
Recife 3
San Francisco 3
Seattle 3
São Bernardo do Campo 3
São Vicente 3
Tampa 3
Thái Bình 3
Verona 3
Allentown 2
Amsterdam 2
Aracaju 2
Ascurra 2
Asunción 2
Baghdad 2
Boardman 2
Botucatu 2
Brescia 2
Buffalo 2
Bắc Ninh 2
Cabo Frio 2
Cagliari 2
Campo Grande 2
Casamassima 2
Cascavel 2
Catania 2
Chaguanas 2
Chesapeake 2
City of London 2
Columbus 2
Curitiba 2
Denver 2
Dhaka 2
Erbil 2
Falmouth 2
Ferraz de Vasconcelos 2
Fortaleza 2
Totale 1.945
Nome #
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 70
An epitope platform for safe and effective HTLV-1-immunization: Potential applications for mRNA and peptide-based vaccines 63
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein 62
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 58
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 55
Circumscribing the conformational peptide epitope landscape 54
Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein. 54
Bacterial peptides are intensively present throughout the human proteome 52
Clinical applications of DNA microarray analysis 52
Comparison of dry and wet electroencephalography for the assessment of cognitive evoked potentials and sensor-level connectivity 50
Brain oscillatory processes related to sequence memory in healthy older adults 50
Chapter 33 - Impact of COVID-19 on the brain: Antibodies against brain stem antigens 50
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines 50
Natalizumab treatment affects cognitive performances, fatigue and health related quality of life in Relapsing Multiple Sclerosis 49
A spiking neurocomputational model of high-frequency oscillatory brain responses to words and pseudowords 49
Changes of Cognitive Performances, Fatigue and Health Related Quality of Life in Natalizumab-Treated Relapsing Multiple Sclerosis Patients 48
Charting the peptide crossreactome between HIV-1 and the human proteome 48
A peptide link between HCMV infection, neuronal migration, and psychosis 48
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response 48
H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment 48
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons 47
Cerebrospinal fluid findings in COVID-19 indicate autoimmunity 47
A peptide talk between JC virus and the human host: from silent infection to autoimmunity 46
Reconciling forgetting and memory consolidation: simulating the dissociable effects of neuronal noise levels on cortical memory 46
SARS-CoV-2 and Guillain-Barré Syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism 43
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 42
Zusammensetzungen zur Behandlung von COVID-19-assoziierter Autoimmun-Hirnstamm- Enzephalitis 41
Communicative-pragmatic assessment is sensitive and time-effective in measuring the outcome of aphasia therapy 41
Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes 41
Anti-neuronal and anti-mitochondrial autoantibodies are associated with lower functional status and more severe respiratory symptoms in post COVID syndrome 40
Zika virus and autoimmunity: From microcephaly to Guillain-Barre syndrome, and beyond 40
Massive peptide sharing between viral and human proteomes 40
Impact of COVID‑19 emergency on the psychological well‑being of susceptible individuals 40
Electrophysiological correlates of language improvements after intensive language therapy in patients with chronic post-stroke aphasia 40
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors 39
Does communication make aphasia therapy more efficient?: Evidence from a cross-over randomized controlled trial 38
Geographical variations in sex ratio trends over time in Multiple Sclerosis 38
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 37
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors. 37
COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection 37
Verbal Fluency Impairment in Patients with Clinically Isolated Syndrome Suggestive of Multipla Sclerosis 37
Reconciling forgetting and memory consolidation: Simulating the dissociable effects of neuronal noise levels on cortical memory traces in 30th Annual Computational Neuroscience Meeting 36
Immune Response Against SARS-CoV-2 36
Early and interactive stored-form (symbol) access and combinatorial (rule) processing in constructing constructions: a MMN study 35
Sentence Construction by Stored-Form Retrieval and by Combination: ERP Evidence for Early and Interactive Processing 35
Intensive social interaction for treatment of post-stroke depression in subacute aphasia: The CONNECT trial 34
Peptide matching between Epstein–Barr virus and human proteins 34
EBV-Associated Cancer and Autoimmunity: Searching for Therapies 34
Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins 34
Gender ratio of Multiple Sclerosis in Italy: geographical distribution and trend over 60 years 33
Geographic Differences in the Temporal Trend of Gender Ratio in Multiple Sclerosis 33
Differential effects of intensive language-action therapy on processing grammatical word class and semantics demonstrated by functional magnetic resonance imaging 33
Epitopes for a 2019-nCoV vaccine 32
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude 32
EBV and Molecular Mimicry: Therapeutic Implications 32
Sex ratio of multiple sclerosis: a comparison of distribution and trend over 60 years among different countries 32
Increasing age at disability milestones among MS patients in the MSBase Registry 32
Natural history of multiple sclerosis: have available therapies impacted long-term prognosis? 32
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 31
Increased recruitment of domain general neural networks in language processing following Intensive Language-Action Therapy – fMRI evidence from people with chronic aphasia 31
No human protein is exempt from bacterial motifs, not even one 31
Using language for communication and action makes intensive aphasia therapy more effective: a crossover randomized controlled trial 31
Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia 31
Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry 31
Epitopes for a 2019-nCoV vaccine 31
West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses 31
Relationships between Plasma Osteopontin Levels and Cognitive Performances in Relapsing Multiple Sclerosis: Effect of Natalizumab Treatment 31
Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the Language-associated NMDA 2A protein 30
Proteome-guided search for influenza A B-cell epitopes 30
PSYCHOLOGICAL GENERAL WELL-BEING, COGNITIVE FAILURE, AND INFLAMMATION BIOMARKERS AMONG WORKERS FOUR MONTHS AFTER A MILD/ASYMPTOMATIC SARS-CoV-2 INFECTION 30
Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B 30
Confronting JC virus and Homo sapiens biological signatures 30
Reply concerning the article "Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond" 29
Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical And Meaningful/less Mini-Constructions 29
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. 29
Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial 29
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry 29
The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond 29
Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions 29
Peptidology: short amino acid modules in cell biology and immunology 28
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome 28
Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins 28
From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between T. gondii and NMDARs as a Potential Mechanistic Link 28
Impact of natalizumab treatment on cognitive performance, fatigue and health-related quality of life in relapsing multiple sclerosis 28
Cytomegalovirus infection: The neurodevelopmental peptide signatures 28
How a single amino acid change may alter the immunological information of a peptide 28
The peptide network between tetanus toxin and human proteins associated with epilepsy 27
Peptide profiling of the route from Mahoney to Sabin, and return 27
Cross-Reactivity as a Mechanism Linking Infections to Stroke 26
Treating multiple sclerosis with natalizumab 26
Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis 26
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study 26
Developing an anti-Campylobacter jejuni vaccine 25
Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide 25
Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis 25
Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules 25
Single amino acid repeats connect viruses to neurodegeneration 25
Peptide sharing between viruses and DLX Proteins: a potential cross-reactivity pathway to neuropsychiatric disorders 25
Occupational zoonoses, neurological diseases, and public health: A one health approach 25
Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining 24
Totale 3.669
Categoria #
all - tutte 19.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025718 0 0 0 104 4 230 48 17 18 65 144 88
2025/20261.888 254 351 250 227 67 61 138 56 203 99 131 51
2026/20271.200 107 363 133 597 0 0 0 0 0 0 0 0
Totale 3.806